Fibrinogen
CAS No. 9001-32-5
Fibrinogen( —— )
Catalog No. M37178 CAS No. 9001-32-5
Fibrinogen is a heterodimeric protein that can be cleaved by thrombin. Fibrinogen is a potential marker for cardiovascular disease and plays an important role in metabolism. Its absence can cause fibrinogenemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 36 | In Stock |
|
| 500MG | 83 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFibrinogen
-
NoteResearch use only, not for human use.
-
Brief DescriptionFibrinogen is a heterodimeric protein that can be cleaved by thrombin. Fibrinogen is a potential marker for cardiovascular disease and plays an important role in metabolism. Its absence can cause fibrinogenemia.
-
DescriptionFibrinogen (Bovine) is a selectively proteolyzed molecule and its thrombin-activated assembly into the fibrin clot.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorInterleukin | NF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number9001-32-5
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : < 0.1 mg/mL (insoluble)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Brown JH, et al. The crystal structure of modified bovine fibrinogen. Proc Natl Acad Sci U S A. 2000;97(1):85-90.
molnova catalog
related products
-
Troxerutin
Troxerutin, a natural bioflavonoid isolated from Sophora japonica., has been reported to have many benefits and medicinal properties.
-
erythro-Austrobailig...
erythro-Austrobailignan-6 is an orally active anti-cancer agent. erythro-Austrobailignan-6 inhibits DNA topoisomerase I and II activity. erythro-Austrobailignan-6 induces cell apoptosis and increases phosphorylation of p38 and JNK.
-
Roemerine
Roemerine is a potential active xanthine oxidase(XOD) inhibitor, XOD is a key enzyme in the pathogenesis of hyperuricemia and also a well-known target for the drug development to treat gout.
Cart
sales@molnova.com